What is Baxter International Inc. (BAX) stock price today?

Baxter International Inc. (BAX) is currently trading at $24.35, up 1.88% today.

What is BAX P/E ratio?

Baxter International Inc.'s P/E ratio is -11.46. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is BAX return on equity (ROE)?

Baxter International Inc.'s return on equity (ROE) is -16.60%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is Baxter International Inc.'s market cap?

Baxter International Inc. has a market capitalization of $12.59B.

NYSE · Medical - Instruments & Supplies

Baxter International Inc. (BAX) Stock

$24.35 +1.88% NYSE: BAX Healthcare

Valuation

Metric	Value
Price	$24.35
Market Cap	$12.59B
P/E Ratio	-11.46
P/B Ratio	1.95
P/S Ratio	1.05
EPS (TTM)	$0.00
52-Week High	$30.00
52-Week Low	$15.73
Dividend Yield	0.17%

Financials & Margins

Metric	Value
ROE	-16.60%
ROA	-5.37%
ROCE	-1.69%
Gross Margin	-2.74%
Operating Margin	-2.74%
Net Margin	-9.27%
Debt/Equity	1.56
Current Ratio	1.85

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$12.1B	$10.1B	$10.4B	$10.6B	$11.2B
Operating Profit	$1.4B	$-2.8B	$707.0M	$14.0M	$-308.0M
Net Profit	$1.3B	$-2.4B	$2.7B	$-649.0M	$-957.0M
EPS	$2.53	$-4.83	$5.23	$-1.27	$-1.75
Op Margin	11.1%	-28.3%	6.8%	0.1%	-2.7%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$33.5B	$28.3B	$28.3B	$25.8B	$20.1B
Total Liabilities	$24.4B	$22.4B	$19.8B	$18.8B	$14.0B
Cash	$3.0B	$1.7B	$3.1B	$1.8B	$2.0B
Borrowings	$18.3B	$17.2B	$14.1B	$13.4B	$10.0B

Latest News

3 Reasons to Avoid BAX and 1 Stock to Buy Instead StockStory · Jul 16, 2026 Why Abbott Stock Is Reimagining Its Future Trefis · Jul 16, 2026 AbbVie vs Baxter: One Golden Cross Is Real, One Is a Trap 24/7 Wall St. · Jul 15, 2026 3 Cash-Producing Stocks with Warning Signs StockStory · Jul 15, 2026 Goldman Sachs Adjusts Price Target on Baxter International to $21 From $19, Maintains Neutral Rating MT Newswires · Jul 14, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$2.2B	$1.2B	$1.7B	$1.0B	$845.0M
Investing Cash Flow	$-11.9B	$-1.6B	$2.8B	$-1.1B	$2.3B
Financing Cash Flow	$-738.0M	$-93.0M	$-63.0M	$-31.0M	$-107.0M
Net Cash Flow	$-780.0M	$-1.2B	$1.5B	$-784.0M	$-446.0M
Free Cash Flow	$1.5B	$576.0M	$1.3B	$559.0M	$323.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.14
EV / EBITDA	26.13
FCF Yield	5.61%
Quick Ratio	1.32
Interest Coverage	-0.94
Return 1Y	5.43%
Return 3Y	-29.66%
Return 5Y	-66.65%

Ownership

Insiders Held0.34%

Institutions Held106.04%

Institutions Float Held106.40%

Institutional Holder	Shares	Report Date
Blackrock Inc.	79,400,664	2026-03-31
Pzena Investment Management LLC	64,527,823	2026-03-31
Dodge & Cox Inc.	57,254,570	2026-03-31
FMR, LLC	46,264,804	2026-03-31
Vanguard Capital Management LLC	33,506,975	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
DVADaVita Inc.	$179.25	+1.26%	15.20	$11.51B	0.00%
FMSFresenius Medical Care AG & Co. KGaA	$23.69	-1.86%	12.64	$12.72B	3.63%
ICUIICU Medical, Inc.	$160.32	+2.00%	132.82	$4.01B	0.00%
INFUInfuSystems Holdings, Inc.	$13.56	+1.12%	31.31	$273.66M	0.00%
RMTIRockwell Medical, Inc.	$7.89	-1.62%	-6.22	$31.14M	0.00%

About Baxter International Inc.

Baxter International Inc. is led by CEO Andrew Hider, employs 37,500 people, headquartered in Deerfield, US, publicly traded since 1981.

Baxter International Inc. (BAX) stock trades at $24.35 with a market capitalization of $12.59B. The stock is valued at a price-to-earnings (P/E) ratio of -11.46, price-to-book of 1.95, price-to-sales of 1.05. Over the past 52 weeks the stock has ranged between $15.73 and $30.00, and currently trades 18.8% below its 52-week high. It pays a dividend yielding 0.17%.

On profitability, Baxter International Inc. generates a return on equity (ROE) of -16.60%, return on capital employed of -1.69%, an operating margin of -2.74%, a net profit margin of -9.27%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.31 +0.33% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.67 +1.27%

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks NYSE High ROE Stocks All stock screens

Run Stock Screener Investing Guides